X-ray equipment manufacturer Fischer Imaging experienced recordrevenues and improved earnings in the third quarter (end-October). The Denver company's revenues totaled $19.1 million, a jump of23% from third-quarter results a year ago, when Fischer had
X-ray equipment manufacturer Fischer Imaging experienced recordrevenues and improved earnings in the third quarter (end-October).
The Denver company's revenues totaled $19.1 million, a jump of23% from third-quarter results a year ago, when Fischer had salesof $15.5 million. The company reported earnings of $883,000 comparedto a loss of $4.7 million in the third quarter of 1994. Earningsadjustments last year included a $4.3 million write-down for adiscontinued product and other nonrecurring costs, according tothe company.
"Strong third-quarter results confirm our belief that effortsto reduce costs and improve our sales mix are taking hold,"said Morgan Nields, chairman and CEO.
The results occurred despite start-up costs relating to a newtilt-table interventional C-arm system and a 24% increase in R&Dspending, Nields noted.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.